Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of QLS12010 Capsules in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Conditions
Interventions
QLS12010
Placebo
Start Date
April 5, 2026
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2027
Last Updated
January 15, 2026
NCT07321951
NCT03057860
NCT06158490
NCT05590585
NCT05899816
NCT04921345
Lead Sponsor
Qilu Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions